Sumitomo Pharma America, Inc. drugs
3 results
Aptiom (eslicarbazepine acetate)
(ESLICARBAZEPINE ACETATE)Sumitomo Pharma America, Inc.
Usage: APTIOM is indicated for the treatment of partial-onset seizures in patients aged 4 years and older.
Gemtesa (vibegron)
(vibegron)Sumitomo Pharma America, Inc.
Usage: GEMTESA® is indicated for treating overactive bladder (OAB) symptoms, including urge urinary incontinence, urgency, and urinary frequency in adults and adult males undergoing treatment for benign prostatic hyperplasia (BPH).
Rethymic (allogenic thymocyte-depleted thymus tissue-agdc)
(allogenic thymocyte-depleted thymus tissue-agdc)Sumitomo Pharma America, Inc.
Usage: RETHYMIC® is indicated for immune reconstitution in pediatric patients with congenital athymia. It is not intended for treating severe combined immunodeficiency (SCID).